Faisal Khurshid

Jefferies | Healthcare

Faisal Khurshid is an analyst from Jefferies specializing in the Healthcare sector. Ranked #164 out of 4664 analysts, they have issued 24 stock ratings with a success rate of 80.45% and an average return of 74.13%.

Faisal Khurshid has a well-established track record, with 24 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 80.45% and an average return of 74.13%, underscoring their expertise and ability to identify winning opportunities for investors.

#164

Out of 4664

24

Total Ratings

+80.45%

Success Rate

+74.13%

Average Return

Recent Ratings Analysis

PTCT

May 27, 2026

Target

$85.00

Current

$70.66

Performance

0.00%

Faisal Khurshid rated PTCT as Buy on May 27, 2026, setting a price target of 85. Shares have remained stable near 70.66, leaving the 85 target still in play.

VSTM

Mar 30, 2026

Target

$15.00

Current

$4.25

Performance

-12.37%

On Mar 30, 2026, VSTM was given a Buy rating by Faisal Khurshid, with a target price of 15. Despite the Buy call, shares fell from 4.25 to 4.25, challenging the optimistic stance.

SNDX

Mar 30, 2026

Target

$40.00

Current

$19.61

Performance

-12.77%

SNDX received a Buy rating from Faisal Khurshid on Mar 30, 2026, aiming for 40. The rating hasn’t played out as hoped, with the stock trading 12.77% below expectations.

FDMT

Mar 30, 2026

Target

$21.00

Current

$8.85

Performance

3.27%

On Mar 30, 2026, Faisal Khurshid published a Buy outlook on FDMT, with a target of 21. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 8.85.

PTGX

Mar 19, 2026

Target

$110.00

Current

$102.21

Performance

0.52%

Faisal Khurshid on Mar 19, 2026 assigned PTGX a Outperform rating, with a price target of 110. The recommendation remains pending validation as shares consolidate around 102.21.

INCY

Mar 16, 2026

Target

$94.00

Current

$97.34

Performance

4.67%

On Mar 16, 2026, Faisal Khurshid reaffirmed INCY with a Hold rating, targeting 94. The neutral call matched muted market action of 4.67%.

ALNY

Mar 16, 2026

Target

$330.00

Current

$295.63

Performance

-7.30%

ALNY was rated Hold by Faisal Khurshid on Mar 16, 2026, with a price objective of 330. Investors who stayed cautious avoided some of the 7.30% decline.

ONC

Mar 16, 2026

Target

$290.00

Current

$300.01

Performance

3.58%

On Mar 16, 2026, Faisal Khurshid initiated coverage on ONC with a Hold rating and target of 290. The stock’s lack of movement around 300.01 aligned with a cautious approach.

KYMR

Mar 16, 2026

Target

$110.00

Current

$81.70

Performance

2.64%

Faisal Khurshid issued a Buy recommendation for KYMR on Mar 16, 2026, price target set at 110. The target of 110 remains in play, though confirmation will depend on future moves.

ABVX

Mar 16, 2026

Target

$160.00

Current

$129.73

Performance

5.69%

On Mar 16, 2026, ABVX was evaluated by Faisal Khurshid, who gave a Buy rating and target of 160. This case illustrates how a timely bullish rating can translate into tangible gains of 5.69%.

DSGN

Mar 16, 2026

Target

$15.00

Current

$11.10

Performance

1.00%

Faisal Khurshid rated DSGN as Buy on Mar 16, 2026, setting a price target of 15. Shares have remained stable near 11.1, leaving the 15 target still in play.

COGT

Mar 16, 2026

Target

$55.00

Current

$34.51

Performance

-3.28%

On Mar 16, 2026, COGT was given a Buy rating by Faisal Khurshid, with a target price of 55. The stock traded sideways with a -3.28% move, keeping the bullish thesis unresolved.

INSM

Mar 16, 2026

Target

$228.00

Current

$106.40

Performance

-26.42%

INSM received a Buy rating from Faisal Khurshid on Mar 16, 2026, aiming for 228. The rating hasn’t played out as hoped, with the stock trading 26.42% below expectations.

TRVI

Nov 20, 2025

Target

$16.00

Current

$14.45

Performance

35.68%

On Nov 20, 2025, Faisal Khurshid published a Outperform outlook on TRVI, with a target of 16. Shares gained 35.68%, underscoring the accuracy of the bullish outlook toward 16.

ABCL

Nov 07, 2025

Target

$4.00

Current

$5.44

Performance

39.13%

Faisal Khurshid on Nov 07, 2025 assigned ABCL a Market Perform rating, with a price target of 4. Shares outperformed expectations, climbing 39.13% despite the neutral view.

GLPG

Oct 21, 2025

Target

$40.00

Current

$28.13

Performance

-10.50%

On Oct 21, 2025, Faisal Khurshid reaffirmed GLPG with a Outperform rating, targeting 40. Shares slid 10.50% despite the recommendation, highlighting downside risks.

CTNM

Sep 25, 2025

Target

$20.00

Current

$13.44

Performance

23.76%

CTNM was rated Outperform by Faisal Khurshid on Sep 25, 2025, with a price objective of 20. A bullish response from the market helped close the gap of 6.56 to the target.

STTK

Aug 14, 2025

Target

$2.00

Current

$6.06

Performance

604.32%

On Aug 14, 2025, Faisal Khurshid initiated coverage on STTK with a Outperform rating and target of 2. The stock’s climb of 604.32% since the call highlights the foresight in the rating.

RYTM

Jul 10, 2025

Target

$102.00

Current

$91.42

Performance

2.67%

Faisal Khurshid issued a Outperform recommendation for RYTM on Jul 10, 2025, price target set at 102. The target of 102 remains in play, though confirmation will depend on future moves.

SYRE

Apr 08, 2025

Target

$45.00

Current

$72.51

Performance

514.49%

On Apr 08, 2025, SYRE was evaluated by Faisal Khurshid, who gave a Outperform rating and target of 45. This case illustrates how a timely bullish rating can translate into tangible gains of 514.49%.

NRIX

Mar 17, 2025

Target

$16.00

Current

$17.47

Performance

25.41%

Faisal Khurshid rated NRIX as Market Perform on Mar 17, 2025, setting a price target of 16. Despite the Hold call, shares climbed 25.41% to 17.47, revealing unexpected momentum.

PLRX

Mar 03, 2025

Target

$2.00

Current

$1.24

Performance

-10.14%

On Mar 03, 2025, PLRX was given a Market Perform rating by Faisal Khurshid, with a target price of 2. The rating provided protection from downside risk as the stock fell to 1.24.

ATYR

Feb 18, 2025

Target

$16.00

Current

$0.48

Performance

-87.38%

ATYR received a Outperform rating from Faisal Khurshid on Feb 18, 2025, aiming for 16. The rating hasn’t played out as hoped, with the stock trading 87.38% below expectations.

ANIP

Dec 11, 2024

Target

$80.00

Current

$81.76

Performance

38.18%

On Dec 11, 2024, Faisal Khurshid published a Outperform outlook on ANIP, with a target of 80. Shares gained 38.18%, underscoring the accuracy of the bullish outlook toward 80.

Frequency Asked Questions

Who is Faisal Khurshid?

Faisal Khurshid is an analyst from Jefferies specializing in the Healthcare sector.

What is Faisal Khurshid's success rate?

Faisal Khurshid currently has a success rate of +80.45%.

How many ratings has Faisal Khurshid issued?

Faisal Khurshid has issued 24 stock ratings so far.

What is the average return of Faisal Khurshid's calls?

Their stock ratings have generated an average return of +74.13%.

What is Faisal Khurshid's ranking?

Faisal Khurshid is ranked #164 out of 4664 analysts.

What types of ratings does Faisal Khurshid give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Faisal Khurshid?

You can follow Faisal Khurshid by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Faisal Khurshid?

Their latest rating was a Buy on PTCT issued on 2026-05-27.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep